학술논문

Exploring the reasons behind Ocrelizumab infusions delay during the first wave of COVID-19 pandemic in Italy: results of a survey among MS centers
Document Type
Journal
Source
MULTIPLE SCLEROSIS JOURNAL; OCT 2022, 28 3_SUPPL, p869-p870, 2p. Supplement: 3_
Subject
Language
English
ISSN
14770970